What's Happening?
Amperos Health has successfully raised $16 million in a Series A funding round led by Bessemer Venture Partners, with additional investments from Uncork Capital and Neo. This funding follows a previous $4.2 million seed round in June 2025. The company
has developed an AI-native, end-to-end denial management platform designed to streamline the process of handling healthcare claims. Unlike traditional tools that only assist with drafting appeal letters or predictive scoring, Amperos' platform utilizes advanced AI to autonomously navigate payer portals, contact insurers, and submit corrected claims. The platform is supported by a team of experts who oversee complex claims, ensuring high recovery rates. Amperos reports that its platform resolves denials five times faster than conventional methods, reduces costs by up to 50%, and increases revenue recovery by over 20% per claim.
Why It's Important?
The introduction of Amperos Health's AI platform addresses significant inefficiencies in the healthcare revenue cycle management (RCM) sector. With approximately 12% of healthcare claims being denied annually, resulting in a $262 billion loss for providers, the platform offers a solution to a critical financial challenge. By automating the denial management process, Amperos not only reduces operational costs but also enhances recovery rates, providing substantial financial relief to healthcare providers. This innovation is particularly crucial as it allows healthcare systems to combat the increasing use of algorithms by insurers to deny claims, thereby leveling the playing field. The platform's ability to adapt to changing payer behaviors ensures that healthcare providers can maintain financial stability and focus on patient care.
What's Next?
With the new funding, Amperos Health plans to expand its platform's capabilities into other areas of revenue cycle management and enhance its analytics features. This growth will enable the company to fill existing gaps in the RCM workforce, allowing staff to concentrate on more complex claims that require human intervention. As the platform continues to evolve, it is expected to further improve efficiency and financial outcomes for healthcare providers. The company's strategic growth will likely attract more healthcare systems seeking to optimize their revenue cycles and reduce the financial burden of claim denials.
